Budget 2023: Government Health Research Investment Underwhelms

Budget 2023: Government Health Research Investment Underwhelming – again media release 22nd May 2023 “New Zealanders have once again been let down by Budget 2023’s underwhelming support for health research” New Zealanders for Health Research (NZHR) Chief Executive Chris Higgins said today. “Health research and innovation is the single most important way in which we…

Read More

Therapeutic Products Bill

Following our written submission to Parliament’s Health Committee we have followed up with an oral submission where we’ve referenced submissions from NZHR members Douglas Pharmaceuticals, Malaghan Institute and MSD (Merck) in order to amplify both their voices and our own. The text of the oral submission can be read here

Read More

NZHR submission on the Therapeutic Products Bill

NZHR has made a submission on the Therapeutic Products Bill. Because products used in clinical trials are yet to be confirmed or otherwise as being therapeutic they need to be unambiguously exempted from many of the Bill’s provisions. It is also important that the new legislation does not impose additional burdens on the carrying out…

Read More

The (New) New Zealand System – Research and Clinical Trials

On 29th November 2022 at NZHR’s “health research at crossroads” workshop Dr Ian Town, Chief Science Advisor, Ministry of Health, presented on the place and role of health research and clinical trials in New Zealand’s reformed health sector. His presentation can be viewed here

Read More

The economic value of health research – Feasibility study

On 29th November 2022 at NZHR’s “health research at crossroads” workshop Sarah Hogan, Principal Economist, New Zealand Institute of Economic Research (NZIER), presented findings from and NZHR commissioned report into the economic value of investing in health research. Her presentation can be viewed here

Read More

Submission to Finance Minister re 2023 Budget Policy Statement and Budget

NZHR has over several years repeatedly called for investment in health research to be substantially increased. However, government investment in health research has historically stagnated somewhere between about 0.6% and 0.8% of government health care costs and in the absence of any indications to the contrary is forecast to fall to 0.51% after 2025/26 when…

Read More

NZHR presentation to the Queenstown Research Week plenary session on “the future of the New Zealand research system”

NZHR’s Chief Executive Chris Higgins was the lead presenter at this event alongside HRC Chief Executive Sunny Collings, MBIE Chief Science Advisor Gary Evans, and the Prime Minister’s Chief Science Advisor Juliet Gerrard. Our presentation focussed on the role of health research in addressing New Zealand’s amenable and non-amenable premature mortality figures including inequitable outcomes…

Read More